FDA expanded use of eye drug
July 29, 2014 at 22:29 PM EDT
Regeneron said the U.S. Food and Drug Administration has approved the use of Eylea for the treatment of diabetic macular edema.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.